Optimization of CD34+ collection for autologous transplantation using the evolution of peripheral blood cell counts after mobilization with chemotherapy and G-CSF

被引:10
作者
Delamain, MT
Metze, K
Marques, JFC
Reis, ARC
De Souza, CA
Lorand-Metze, I
机构
[1] Univ Estadual Campinas, Fac Med, Dept Internal Med, BR-13081970 Campinas, SP, Brazil
[2] Univ Estadual Campinas, Fac Med, Dept Pathol, BR-13081970 Campinas, SP, Brazil
[3] Univ Estadual Campinas, Hematol Hemotherapy Ctr, BR-13081970 Campinas, SP, Brazil
关键词
PBPC collection; autologous transplantation; apheresis; CD34+cells; peripheral blood progenitor cell; mobilization; transplantation;
D O I
10.1016/j.transci.2005.09.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Peripheral blood progenitor cells (PBPC) collection after high dose chemotherapy can be influenced by several factors. We searched for parameters that may predict the best day to start harvesting of PBPC in order to collect most CD34+ cells with the least number of aphereses. Methods: We studied patients who underwent mobilization chemotherapy for autologous transplantation. The influence of age, sex, diagnosis, number of previous chemotherapy cycles, peripheral blood (PB) counts at day of mobilization (D0), day of neutrophils < 1.0 x 10(9) l(-1) and day of nadir and interval between both (delta) on harvesting was investigated. Multivariate linear correlation models were built to predict the best harvesting with principles of parsimony. In patients where sequential CD34+ cell count was performed, the theoretical day of peak was calculated by interpolation in polynomial regression. Results: One hundred and thirty four patients entered the analysis: 36 Hodgkin's lymphoma (HL), 65 B-large cell lymphoma (NHL) and 33 multiple myeloma (MM). Day of harvesting correlated with nr CHT, hemoglobin on DO, day of granulocytes < 1.0 x 10(9) l(-1), delta and dosis of mobilization therapy. The day of CD34+ peak could be calculated by the formula = (-0.41) x Hemoglobin D0 + (day peripheral CD34+ cells = 10 X 10(6) mu l(-1)) x 0.99 + 7.8. This model could explain 81% of the variance of the peak day and was stable by bootstrap resampling. Day of peripheral CD34+ cells = 10 X 10(6) mu l(-1) preceded the calculated peak by 3-9 days. Conclusions: Although the day of best collection can be predicted using only sequential PB counts after mobilization chemotherapy, a model of prediction using peripheral CD34+ cell count is important especially for optimizing collection in poor mobilizing patients. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:33 / 40
页数:8
相关论文
共 43 条
[1]   Large-volume leukapheresis yields more viable CD34+cells and colony-forming units than normal-volume leukapheresis, especially in patients who mobilize low numbers of CD34+cells [J].
Abrahamsen, JF ;
Stamnesfet, S ;
Liseth, K ;
Hervig, T ;
Bruserud, O .
TRANSFUSION, 2005, 45 (02) :248-253
[2]   A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J].
Attal, M ;
Harousseau, JL ;
Stoppa, AM ;
Sotto, JJ ;
Fuzibet, JG ;
Rossi, JF ;
Casassus, P ;
Maisonneuve, H ;
Facon, T ;
Ifrah, N ;
Payen, C ;
Bataille, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :91-97
[3]   Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies [J].
Carral, A ;
de la Rubia, J ;
Martín, G ;
Mollá, S ;
Martínez, J ;
Soler, MA ;
Jarque, I ;
Jiménez, C ;
Sanz, MA .
LEUKEMIA RESEARCH, 2003, 27 (01) :5-12
[4]   Previous treatment predicts the efficiency of blood progenitor cell mobilisation: validation of a chemotherapy scoring system [J].
Clark, RE ;
Brammer, CG .
BONE MARROW TRANSPLANTATION, 1998, 22 (09) :859-863
[5]   Blood stem cell collections in multiple myeloma: definition of a scoring system [J].
Corso, A ;
Caberlon, S ;
Pagnucco, G ;
Klersy, C ;
Zappasodi, P ;
Alessandrino, EP ;
Vanelli, L ;
Mangiacavalli, S ;
Lazzarino, M ;
Bernasconi, C .
BONE MARROW TRANSPLANTATION, 2000, 26 (03) :283-286
[6]   Bone marrow CD34+ cell count is predictive for adequate peripheral progenitor cell collection [J].
Corso, A ;
Varettoni, M ;
Mangiacavalli, S ;
Zappasodi, P ;
Klersy, C ;
Rusconi, C ;
Colucci, E ;
Lorenzi, A ;
Troletti, D ;
Consensi, E ;
Lazzarino, M .
LEUKEMIA RESEARCH, 2005, 29 (02) :159-163
[7]  
D'Arena G, 1998, AM J HEMATOL, V58, P255, DOI 10.1002/(SICI)1096-8652(199808)58:4<255::AID-AJH1>3.0.CO
[8]  
2-P
[9]   Circulating CD34+ absolute cell number is the best single parameter to predict the quality of leukapheretic yield [J].
D'Arena, G ;
Musto, P ;
Cascavilla, N ;
Scalzulli, PR ;
Dello Iacono, N ;
Carotenuto, M .
BONE MARROW TRANSPLANTATION, 1998, 22 (02) :215-216
[10]   Monitoring of CD34+ cells during leukapheresis allows a single, successful collection of hemopoietic progenitors in patients with low numbers of circulating stem cells [J].
de Fabritiis, P ;
Gonzalez, M ;
Meloni, G ;
De Propris, MS ;
Bellucci, R ;
Cordone, I ;
Gozzer, M ;
Leone, G ;
Mandelli, F .
BONE MARROW TRANSPLANTATION, 1999, 23 (12) :1229-1236